DeutschNewstral
Article
The Times of India on 2021-06-30 22:36
Brazil suspends Bharat Biotech's Covaxin order for 20m doses
Related news
Brazil suspends Bharat Biotech's Covaxin clinical trialsThe Hindu- Coronavirus live updates | Bharat Biotech to make 6 crore Covaxin doses by JulyThe Hindu
- Bharat Biotech terminates Covaxin pact with Brazil partnersThe Times of India
- Coronavirus | Bharat Biotech to make 6 crore Covaxin doses by JulyThe Hindu
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
- Covaxin safe for kids: Bharat BiotechThe Times of India
- Bharat Biotech clarifies on COVAXIN usageThe Hindu
- Bharat Biotech's nasal vaccine will be used as booster doseThe Times of India
- CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldThe Hindu
- DCGI approves Bharat Biotech's intranasal booster dose trialsThe Times of India
- Can Bharat Biotech's nasal vaccine be a gamechanger?The Times of India
- Coronavirus | After SII, Bharat Biotech seeks DCGI approval for CovaxinThe Hindu
- Coronavirus | Covaxin trial participants could test positive, says Bharat BiotechThe Hindu
- Slowing down Covaxin output across plants: Bharat BiotechThe Times of India
- Serum Institute's and Bharat Biotech's COVID-19 vaccine applications put on holdThe Hindu
- Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in CanadaThe Hindu
- Bharat Biotech yet to start supply of May order of Covaxin: CentreThe Hindu
- 1 Covaxin dose to survivor = 2 doses to uninfectedThe Times of India
Zim acquires 20m Covid-19 doseschronicle.co.zw- Covaxin demonstrates robust safety and immunogenicity in children 2-18 years: Bharat BiotechThe Hindu